Cabio Biotech (Wuhan) Co., Ltd. (SHA:688089)
11.65
+0.09 (0.78%)
Jun 23, 2026, 3:00 PM CST
-51.38% (1Y)
| Market Cap | 1.92B -55.9% |
| Revenue (ttm) | 418.18M -29.7% |
| Net Income | 55.16M -61.9% |
| EPS | 0.33 -62.2% |
| Shares Out | 164.51M |
| PE Ratio | 35.34 |
| Forward PE | n/a |
| Dividend | 0.20 (1.73%) |
| Ex-Dividend Date | Jul 10, 2025 |
| Volume | 2,833,789 |
| Open | 11.66 |
| Previous Close | 11.56 |
| Day's Range | 11.57 - 12.03 |
| 52-Week Range | 10.93 - 31.13 |
| Beta | 0.25 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 19, 2026 |